News Focus
News Focus
icon url

genisi

07/29/13 3:11 AM

#164609 RE: DewDiligence #164605

Teva’s thrice-weekly Copaxone

The UBS analyst (Marc Goodman) also noted as we did (#msg-80403825) that if Copaxone generics enter the market in May 2014, Teva will not have time to switch patients to the thrice-weekly version.